Inhibitors
Cat.No. | Name | Information |
---|---|---|
M1672 | BI 2536 | BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. |
M13721 | TAK-960 dihydrochloride | TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM. |
M13720 | Rigosertib sodium | Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. |
M13719 | Rigosertib | Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. |
M13718 | Onvansertib | NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM. |
M13717 | HMN-214 | HMN-214, an orally bioavailable prodrug of HMN-176, is an inhibitor of polo-like kinase-1 (plk1), with antitumor activity. |
M9307 | TC-S 7005 | TC-S 7005 is a potent and selective polo-like kinase 2 (PLK2) inhibitor (IC50 = 4 nM). |
M9250 | HMN-176 | HMN-176 inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization. |
M8519 | Mps1-IN-2 | Mps1-IN-2 is a potent and selective inhibitor of Mps1 kinase. |
M7559 | ON1231320 | ON1231320, also known as GBO-006, is a Polo-like kinase 2 (PLK2) inhibitor. In vitro testing revealed that ON1231320 is a selective inhibitor of PLK2 with no inhibitory activity against PLK1, PLK3 and PLK4. |
M7271 | SBE13 hydrochloride | SBE13 hydrochloride is a potent and selective PLK1 inhibitor. |
M3293 | HMN-214 | HMN-214 is a procompound of HMN-176, which alters the cellular spatial orientation of Plk1. |
M3198 | TAK-960 | TAK-960 is a novel, potent and selective Plk1 inhibitor with IC50 of 8 nM. |
M2983 | Ro3280 | RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM. |
M2860 | MLN0905 | MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM. |
M2741 | GW843682X | GW 843682X is a PLK inhibitor for PLK1 and PLK3 with IC50 of 2.2 nM and 9.1 nM, respectively. |
M2211 | Rigosertib sodium | Rigosertib sodium is a dual non-ATP inhibitor of polo-like kinase 1 (Plk1) and phosphoinositide 3-kinase pathways (PI3K). |
M1719 | GSK461364 | GSK461364 is a potent and selective small molecule inhibitor of Polo-like kinase 1 (PLK1) with a Ki of 2.2 nM. |
M1678 | BI 6727 | BI 6727 (Volasertib) is a small highly potent Polo-like kinase inhibitor (Plk1) with an IC50 of 0 .87 nM. |
M1672 | BI 2536 | BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.